As of June 2024 Kindred Biosciences has a market cap of $0.42 Billion. This makes Kindred Biosciences the world's 6221th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2022 | $0.42 B | 0% |
2021 | $0.42 B | 147.33% |
2020 | $0.17 B | -48.86% |
2019 | $0.33 B | -10.57% |
2018 | $0.37 B | 39.7% |
2017 | $0.26 B | 214.37% |
2016 | $84.64 M | 25.5% |
2015 | $67.44 M | -54.1% |
2014 | $0.14 B | -18.87% |
2013 | $0.18 B |
Name | Market cap | Market cap differencediff. | Country |
---|---|---|---|
Eli Lilly LLY | $779.65 B | 185,299.89% | ๐บ๐ธ USA |
Zoetis ZTS | $77.36 B | 18,298.23% | ๐บ๐ธ USA |
Merck MRK | $317.96 B | 75,512.15% | ๐บ๐ธ USA |
Phibro Animal Health
PAHC | $0.71 B | 69.81% | ๐บ๐ธ USA |
Heska Corporation
HSKA | $1.30 B | 211.41% | ๐บ๐ธ USA |
Petco WOOF | $1.04 B | 148.79% | ๐บ๐ธ USA |